Donald B Milder's Net Worth
$892 Million
Who is Donald B Milder?
Donald B Milder has an estimated net worth of $892 Million. This is based on reported shares across multiple companies, which include INSULET CORP, PHASERX, INC., GLAUKOS Corp, NOVACEA INC, Inogen Inc, GENOMIC HEALTH INC, Alexza Pharmaceuticals Inc., HELICOS BIOSCIENCES CORP, Flexion Therapeutics Inc, Inari Medical, Inc., INTRALASE CORP, and SECOND SIGHT MEDICAL PRODUCTS INC.
SEC CIK
Donald B Milder's CIK is 0001279660
Past Insider Trading and Trends
2014 was Donald B Milder's most active year for acquiring shares with 70 total transactions. Donald B Milder's most active month to acquire stocks was the month of October. 2021 was Donald B Milder's most active year for disposing of shares, totalling 53 transactions. Donald B Milder's most active month to dispose stocks was the month of April. 2016 saw Donald B Milder paying a total of $12,999,990.00 for 1,449,369 shares, this is the most they've acquired in one year. In 2022 Donald B Milder cashed out on 709,983 shares for a total of $6,228,118.47, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PHASERX, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +21.36% | 341.96K |
$2.51 | $2,997,419.56 | 1.94M |
May 23
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Inogen Inc (INGN) Snapshot price: $7.505
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
| -10.90% | -374.67K |
$24.30 | -$179,534.67 | 3.06M |
Nov 5 - Nov 7
| |||
Form 4
| -31.05% | -706.33K |
—
|
—
| 1.57M |
Jan 6 - Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4/A
| -16.87% | -464.29K |
—
|
—
| 2.29M |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -16.87% | -464.29K |
—
|
—
| 2.29M |
Dec 18
| |||
Form 4
| -11.64% | -5.34K |
$24.89 | -$132,961.62 | 40.57K |
Nov 17
| |||
Form 4
| -21.11% | -728.10K |
$25.13 | -$237,069.89 | 2.72M |
Nov 12 - Nov 14
| |||
Form 4
| -19.71% | -2.99K |
$24.42 | -$73,064.94 | 12.19K |
Nov 10
| |||
Form 4
| +11.02% | 14.47K |
$24.30 | -$179,534.67 | 145.72K |
Nov 5 - Nov 7
| |||
Form 4
| -100.00% | -4.65K |
$20.76 | -$96,455.46 |
0
|
Oct 24
| |||
Form 4
| -100.00% | -1.90K |
$20.83 | -$39,568.45 |
0
|
Oct 9
| |||
Form 4
| -40.23% | -27.52K |
$21.03 | -$145,230.72 | 40.89K |
Oct 7 - Oct 8
| |||
Form 4
| -10.48% | -398.20K |
$23.25 | -$171,768.04 | 3.4M |
Sep 9
| |||
| No matching records found | |||||||||
SECOND SIGHT MEDICAL PRODUCTS INC (VANI) Snapshot price: $1.01
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NOVACEA INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.07M |
—
|
—
| 2.07M |
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GENOMIC HEALTH INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +142.77% | 2.37M |
—
|
—
| 4.02M |
Oct 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||